BML, Inc.
BML, Inc.
Aktie · JP3799700004 (XTKS)
Übersicht
Kein Kurs
Schlusskurs XTKS 04.11.2025: 3.680,00 JPY
04.11.2025 05:38
Aktuelle Kurse von BML, Inc.
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XTKS: Tokyo
Tokyo
4694.T
JPY
04.11.2025 05:38
3.680,00 JPY
50,00 JPY
+1,38 %
Free Float & Liquidität
Free Float 42,99 %
Shares Float 16,77 M
Ausstehende Aktien 39,01 M
Investierte Fonds

Folgende Fonds haben in BML, Inc. investiert:

Fonds
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in Mio
12,63
Anteil (%)
0,02 %
Fonds
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in Mio
30,93
Anteil (%)
0,02 %
Firmenprofil zu BML, Inc. Aktie
BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures; and provides electronic medical charts for networking medical information, as well as offers preventive medicine services. In addition, the company provides food sanitation control and food processing services comprising contract services for microorganism testing of raw materials, and prepared and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.
Erhalte tagesaktuelle Insights vom finAgent über BML, Inc.

Unternehmensdaten

Name BML, Inc.
Firma BML, Inc.
Website https://www.bml.co.jp
Heimatbörse XTKS Tokyo
ISIN JP3799700004
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Kensuke Kondo
Marktkapitalisierung 143 Mrd.
Land Japan
Währung JPY
Mitarbeiter 4,5 T
Adresse 5-21-3 Sendagaya, Tokyo
IPO Datum 2001-04-25
Dividenden von 'BML, Inc.'
Ex-Datum Dividende pro Aktie
29.09.2025 60,00 JPY

Ticker Symbole

Name Symbol
Tokyo 4694.T
Weitere Aktien
Investoren, die BML, Inc. halten, haben auch folgende Aktien im Depot:
MFS M.-EUR.RESEARCH I1 EO
MFS M.-EUR.RESEARCH I1 EO Fonds
XBRANE BIOPHARMA AB
XBRANE BIOPHARMA AB Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025